Stock analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a research report issued on Thursday. The brokerage set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Price Performance
Global Cord Blood stock opened at $1.50 on Thursday. Global Cord Blood has a twelve month low of $2.03 and a twelve month high of $5.50. The company has a 50 day moving average of $1.47 and a 200-day moving average of $1.35. The stock has a market capitalization of $182.33 million, a PE ratio of 2.34 and a beta of 0.16.
Global Cord Blood Company Profile
Featured Stories
- Five stocks we like better than Global Cord Blood
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What is the FTSE 100 index?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- The Most Important Warren Buffett Stock for Investors: His Own
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.